The Mouth-Body Connection: How a Common Oral Bacterium May Fuel Breast Cancer

BALTIMORE — A common bacterium typically associated with gum disease may play a silent, supporting role in the development and spread of breast cancer, according to new research from the Johns Hopkins Kimmel Cancer Center.

The study, published January 15, 2026, in Cell Communication and Signaling, reveals that Fusobacterium nucleatum—an inhabitant of the human mouth—can travel through the bloodstream to breast tissue. Once there, it may trigger a cascade of cellular changes that not only spark tumor growth but also help cancer cells migrate to other organs.

While the link between oral health and systemic diseases like heart disease is well-documented, this research provides a mechanistic “smoking gun” for how periodontal pathogens might influence breast malignancy, particularly in women with genetic predispositions.

A Hidden Passenger in the Breast

Fusobacterium nucleatum (F. nucleatum) is a prolific member of the oral microbiome. In a healthy mouth, it is relatively harmless. However, when gum disease (periodontitis) occurs, the bacteria can enter the bloodstream through bleeding gums.

Previous studies have linked F. nucleatum to colorectal and pancreatic cancers. This new research, led by Dipali Sharma, Ph.D., a professor of oncology at Johns Hopkins, sought to determine if the microbe could also reach and affect breast tissue.

“The key takeaway is that this oral microbe can reside in breast tissue and that there is a connection between this pathogen and breast cancer,” says Dr. Sharma. Her team’s investigation was prompted by large-scale epidemiological data showing a statistical correlation between severe gum disease and increased breast cancer risk.

How the Bacterium “Wires” Cells for Cancer

The research team utilized animal models and human breast cell cultures to observe the bacterium’s impact. The findings suggest that F. nucleatum is not merely a passive bystander; it actively alters the environment of the breast.

1. Pre-Cancerous Lesions

When the bacteria were introduced into the breast ducts of mice, the tissue began to show signs of metaplasia and hyperplasia—conditions where cells grow abnormally or change their identity. While these lesions are not yet cancerous, they are often the precursors to malignancy.

2. DNA Damage and Error-Prone Repair

One of the study’s most significant findings involved the bacterium’s ability to injure cellular DNA. Exposure to F. nucleatum activated a specific repair pathway known as nonhomologous end joining (NHEJ).

“NHEJ is a fast but error-prone way that cells repair broken DNA,” the researchers noted. By forcing the cell to use this “quick-fix” method, the bacterium increases the likelihood of genetic mutations that lead to cancer.

3. Increased Aggression and Resistance

The study identified a protein called PKcs that becomes more active after even brief exposure to the bacteria. This protein is associated with:

• Migration: The ability of cancer cells to move.

• Invasion: The ability to penetrate surrounding tissues.

• Stem-like behavior: Making cancer harder to eradicate.

• Chemoresistance: Reducing the effectiveness of standard treatments.

The Genetic Connection: BRCA1 Vulnerability

The research highlights a particularly concerning synergy for individuals with BRCA1 mutations. These mutations already impair a cell’s ability to repair DNA, making them more susceptible to cancer.

Dr. Sharma’s team found that BRCA1-mutant cells possess higher levels of a specific surface sugar called Gal-GalNAc. This sugar acts like a “velcro” for F. nucleatum, allowing the bacteria to bind to and enter the cells more easily. Once inside, the bacteria were retained for longer periods, even as the cells divided, amplifying the damage over time.

“Our findings suggest that multiple risk factors come together,” says Dr. Sharma. “F. nucleatum acts as an environmental factor that may cooperate with inherited BRCA1 mutations to promote breast cancer and tumor aggressiveness.”

Expert Perspectives

Independent experts suggest that while these findings are groundbreaking, they require a nuanced interpretation.

“This adds to the growing body of evidence regarding the ‘oncomicrobiome’—the idea that our internal bacterial landscape dictates cancer risk,” says Dr. Elena Rossi, an oncologist not involved in the study. “However, it is important to remember that this study used animal models and cell lines. We need clinical trials to confirm if treating gum disease can directly lower breast cancer recurrence or incidence in humans.”

What This Means for You

While the science is evolving, the practical implications for public health are clear: Oral hygiene is not just about your teeth.

• Prioritize Periodontal Health: Regular flossing and professional cleanings reduce the bacterial load in the mouth and prevent the bleeding that allows bacteria to enter the blood.

• Be Proactive if High-Risk: For those with known BRCA1 mutations or a family history of breast cancer, maintaining meticulous oral health may be a low-cost, high-reward preventative measure.

• Don’t Panic: Having F. nucleatum in your mouth does not mean you will develop breast cancer. It is one factor in a complex web of genetics, lifestyle, and environment.

Study Limitations

The researchers acknowledge that while the mouse models mimic human breast cancer, they are not a perfect substitute for the human body’s complex immune response. Furthermore, the study focused on a specific bacterium; the role of the wider oral microbiome remains a subject for future investigation.

Statistical Context

• 1 in 8: The number of women in the U.S. who will develop invasive breast cancer in their lifetime.

• 47%: The percentage of adults aged 30 and older who have some form of periodontal disease, according to the CDC.

• Linkage: Previous epidemiological studies have suggested that women with periodontal disease may face a 14% to 22% higher risk of developing breast cancer compared to those with healthy gums.

Reference Section

Peer-Reviewed Study:

• Parida, S., Nandi, D., Verma, D., et al. (2026). “A pro-carcinogenic oral microbe internalized by breast cancer cells promotes mammary tumorigenesis.” Cell Communication and Signaling. DOI: 10.1186/s12964-025-02635-9.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.